Expression of receptor activator of NF-kB ligand (RANKL) on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.

被引:0
|
作者
Heider, U
Jakob, C
Zavrski, I
Langelotz, C
Fleissner, C
Schulz, CO
Eucker, J
Possinger, K
Hofbauer, LC
Sezer, O
机构
[1] Universitatsklinikum Charite, Dept Hematol & Oncol, Berlin, Germany
[2] Univ Marburg, Dept Gastroenterol Endocrinol & Metab, D-35032 Marburg, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3190
引用
收藏
页码:808A / 808A
页数:1
相关论文
共 50 条
  • [41] Osteoclasts activation by receptor activator of NF-κB ligand (RANKL) enhanced the mobilization of hematopoietic progenitor cells from the bone marrow in acute injury
    Cho, Kyung-Ah
    Ju, Sun-Young
    Ryu, Kyung-Ha
    Woo, So-Youn
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [42] MIR-16 REGULATES CROSSTALK IN NF-KB INFLAMMATORY SIGNALING BETWEEN MYELOMA CELLS AND BONE MARROW MACROPHAGES (MQ)
    Khalife, Jihane
    Viola, Domenico
    EXPERIMENTAL HEMATOLOGY, 2018, 64 : S77 - S77
  • [43] Gene Expression Profiling of Bone Marrow Endothelial Cells in Patients with Multiple Myeloma
    Ria, Roberto
    Todoerti, Katia
    Berardi, Simona
    Coluccia, Addolorata Maria Luce
    De Luisi, Annunziata
    Mattioli, Michela
    Ronchetti, Domenica
    Morabito, Fortunato
    Guarini, Attilio
    Petrucci, Maria Teresa
    Dammacco, Franco
    Ribatti, Domenico
    Neri, Antonino
    Vacca, Angelo
    CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5369 - 5378
  • [44] Association of the polymorphisms in receptor activator of NF-kB (RANK) and RANK ligand gene with bone mineral density in postmenopausal Korean women.
    Kim, J.
    Kim, J.
    Lee, D.
    Kim, J.
    Jee, B.
    Ku, S.
    Kim, S.
    Choi, Y.
    Moon, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S361 - S361
  • [45] Effect of pamidronate on bone marrow plasma cells and on IL-6, sIL-6R in patients with multiple myeloma.
    Giuliani, N
    Bologna, G
    Pedrazzoni, M
    Girasole, G
    Passeri, G
    Quaini, F
    Passeri, M
    Sansoni, P
    BONE, 1999, 25 (01) : 159 - 159
  • [46] Kaliotoxin decreases receptor activator of NFκB ligand (RANKL) expression in activated T cells in vitro and ameliorates local inflammatory bone resorption in experimental periodontal disease
    Valverde, P
    Kawai, T
    Taubman, MA
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S213 - S213
  • [47] The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma
    Ghosh, Toshi
    Gonsalves, Wilson I.
    Jevremovic, Dragan
    Dispenzieri, Angela
    Dingli, David
    Timm, Michael M.
    Morice, William G.
    Kapoor, Prashant
    Kourelis, Taxiarchis V.
    Lacy, Martha Q.
    Hayman, Suzanne R.
    Buadi, Francis K.
    Leung, Nelson
    Go, Ronald S.
    Lin, Yi
    Russell, Stephen J.
    Lust, John A.
    Zeldenrust, Steven R.
    Warsame, Rahma
    Hwa, Yi L.
    Kyle, Robert A.
    Gertz, Morie A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (09) : E507 - E512
  • [48] Prediction Model for Cereblon Expression in Bone Marrow Plasma Cells Based on Blood Markers in Multiple Myeloma Patients
    Lee, Byung-Hyun
    Kang, Ka-Won
    Jeon, Min Ji
    Yu, Eun Sang
    Kim, Dae Sik
    Lee, Se Ryeon
    Sung, Hwa Jung
    Park, Yong
    Choi, Chul Won
    Kim, Byung Soo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] INTERLEUKIN-6 RECEPTOR EXPRESSION AND SATURATION ON THE BONE-MARROW CELLS OF PATIENTS WITH MULTIPLE-MYELOMA
    BROWN, RD
    GORENC, B
    GIBSON, J
    JOSHUA, D
    LEUKEMIA, 1993, 7 (02) : 221 - 225
  • [50] Curcumin Inhibits Osteoclastogenesis by Decreasing Receptor Activator of Nuclear Factor-κB Ligand (RANKL) in Bone Marrow Stromal Cells
    Oh, Sora
    Kyung, Tae-Wook
    Choi, Hye-Seon
    MOLECULES AND CELLS, 2008, 26 (05) : 486 - 489